Medike Holdings' subsidiary completes 200 million yuan capital increase and brings in strategic investor Fuzhou Shaoxin

(March 24, 2026, Hangzhou) Hangzhou Medike Optical Technology Co., Ltd. (Stock Code: 688079, Stock Abbreviation: Medike) announced today that its controlling subsidiary, Zhejiang Medike Optical Semiconductor Co., Ltd. (hereinafter referred to as “Optical Semiconductor Company”), has completed the necessary business registration changes related to its capital increase and has officially introduced the strategic investor Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership) (hereinafter referred to as “Fuzhe Shaoxin”), and has received the full capital increase amount of 200 million yuan.

The announcement indicates that Medike convened its third board meeting on December 10, 2025, where it reviewed and approved the proposal for the capital increase and the introduction of investors for the controlling subsidiary. After a series of procedures, the company, the Optical Semiconductor Company, and Fuzhe Shaoxin have officially signed the capital increase agreement, and the Optical Semiconductor Company has recently completed the business registration changes and obtained the newly issued “Business License.”

According to the latest business license information, the registered capital of the Optical Semiconductor Company has increased from the original 908 million yuan to 1,101.447503 million yuan. The company type is listed as other limited liability company, with Ge Wenzhi as the legal representative. The registered address is located at No. 15, Xinchao Road, Chang’an Town (High-tech Zone), Haining City, Jiaxing, Zhejiang Province.

After the capital increase, the shareholding structure of the Optical Semiconductor Company has changed as follows:

This capital increase will help the Optical Semiconductor Company strengthen its capital strength, optimize its equity structure, and provide financial support for further development in the fields of optoelectronic devices, integrated circuit chips, and product manufacturing. Medike stated that introducing Fuzhe Shaoxin as a strategic investor will benefit the Optical Semiconductor Company by leveraging the resource advantages of the investor to enhance market competitiveness and promote the overall strategic development of the company.

The business scope of the Optical Semiconductor Company includes the manufacturing of optoelectronic devices, electronic components, integrated circuit chips and products, and semiconductor discrete devices. This capital increase will provide strong support for its technological research and development and market expansion in these business directions.

Click here to view the original announcement>>

Disclaimer: The market carries risks, and investment should be approached with caution. This article is automatically published by the AI model based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for any discrepancies. If you have any questions, please contact biz@staff.sina.com.cn.

A wealth of information and precise interpretations can be found in the Sina Finance APP.

Editor: Xiao Lang Kuai Bao